ERSTE Stock Biotec R01 VTA/ AT0000A18XC5 /
NAV2024-04-25 | Chg.+36.2969 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
194,629.9219HUF | +0.02% | Full reinvestment | Equity Sector Biotechnology | Erste AM ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2014 | - | - | - | - | - | - | - | 10.56 | 2.95 | 6.31 | 2.92 | 6.57 | - |
2015 | 11.45 | 4.28 | 5.13 | -4.18 | 10.61 | -1.30 | 5.50 | -7.32 | -17.86 | 14.82 | 7.76 | -2.91 | +23.32% |
2016 | -26.53 | -1.59 | -4.77 | 8.88 | 3.63 | -6.64 | 11.02 | -2.64 | 3.01 | -6.30 | 12.59 | -5.41 | -19.41% |
2017 | 0.71 | 9.05 | -1.97 | 1.35 | -8.66 | 8.04 | -0.28 | 0.15 | 5.20 | -3.80 | -2.84 | 3.87 | +9.84% |
2018 | 2.33 | -1.99 | -4.32 | 1.44 | 10.03 | 4.85 | 0.96 | 9.99 | -2.12 | -14.11 | 2.87 | -13.10 | -6.29% |
2019 | 16.36 | 9.53 | -3.63 | 0.27 | -3.63 | 4.17 | 3.02 | -4.51 | -4.26 | 4.23 | 14.57 | -0.84 | +37.88% |
2020 | -2.06 | -2.89 | -0.46 | 13.15 | 2.21 | 1.81 | -7.36 | -2.88 | 4.72 | 1.06 | -1.08 | 2.92 | +8.06% |
2021 | 2.22 | -2.50 | -2.36 | -1.51 | -7.69 | 9.35 | -0.24 | 1.14 | 0.51 | -1.16 | -0.22 | 1.44 | -1.86% |
2022 | -13.77 | 0.16 | 5.61 | 1.83 | -0.92 | 3.52 | 9.41 | 0.85 | 5.92 | 3.73 | -3.09 | -5.25 | +6.03% |
2023 | -2.30 | -5.24 | -1.51 | -0.34 | -0.52 | -1.02 | 3.81 | -0.55 | 2.64 | -9.61 | -0.93 | 14.40 | -2.85% |
2024 | 2.48 | 5.72 | -2.44 | -6.42 | - | - | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 17.98% | 20.09% | 18.80% | 24.30% | 26.44% |
Sharpe ratio | -0.41 | 0.66 | -0.03 | -0.12 | 0.02 |
Best month | +14.40% | +14.40% | +14.40% | +14.40% | +14.57% |
Worst month | -6.42% | -9.61% | -9.61% | -13.77% | -13.77% |
Maximum loss | -10.54% | -10.54% | -12.13% | -24.25% | -29.00% |
Outperformance | -1.51% | - | -7.87% | -33.09% | -35.72% |
All quotes in HUF
Tranches
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
ERSTE Stock Biotec D02 VTIA | Full reinvestment | 2,850.9500 | +5.99% | -7.39% | |
ERSTE Stock Biotec D02 VTIA | Full reinvestment | 46,476.2617 | +4.50% | +5.46% | |
ERSTE Stock Biotec D02 VTIA | Full reinvestment | 115.3900 | -0.85% | -4.63% | |
ERSTE Stock Biotec D01 A | paying dividend | 112.5200 | -1.48% | -5.24% | |
ERSTE Stock Biotec D01 T | reinvestment | 111.6400 | -1.47% | -5.24% | |
ERSTE Stock Biotec R01 VTA | Full reinvestment | 194,629.9219 | +3.28% | +2.58% | |
ERSTE Stock Biotec R01 VTA | Full reinvestment | 12,477.5098 | +5.93% | -7.44% | |
ERSTE Stock Biotec R01 VTA | Full reinvestment | 494.2000 | -1.48% | -5.24% | |
ERSTE Stock Biotec R01 A | paying dividend | 451.2300 | -1.47% | -5.26% | |
ERSTE Stock Biotec R01 T | reinvestment | 451.2100 | -1.47% | -5.26% |
Performance
YTD | -1.08% | ||
---|---|---|---|
6 Months | +8.20% | ||
1 Year | +3.28% | ||
3 Years | +2.58% | ||
5 Years | +24.26% | ||
Since start | +114.62% | ||
Year | |||
2023 | -2.85% | ||
2022 | +6.03% | ||
2021 | -1.86% | ||
2020 | +8.06% | ||
2019 | +37.88% | ||
2018 | -6.29% | ||
2017 | +9.84% | ||
2016 | -19.41% | ||
2015 | +23.32% |